Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07664956
PHASE4

Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy

Sponsor: Christiana Care Health Services

View on ClinicalTrials.gov

Summary

Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.

Official title: Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy: A Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2026-07-01

Completion Date

2026-12-01

Last Updated

2026-06-24

Healthy Volunteers

No

Interventions

DRUG

Cyclobenzaprine

5mg cyclobenzaprine q8hr for one week postoperatively after minimally invasive hysterectomy

Locations (1)

ChristianaCare Health System

Newark, Delaware, United States